Centering Corporate Activity in the Population Health Research Agenda

Commercial determinants of health drive chronic disease through corporate influence on science, regulation, and public narratives. JAMA Health Forum Editor in Chief Sandro Galea, MD, DrPH, speaks with Laura Schmidt, PhD, MSW, MPH, of University of California, San Francisco, about health equity, industry approaches, and policy solutions. **Related Content:** - Centering Corporate Activity in the Population Health Research Agenda